Literature DB >> 18760864

Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.

Asim Sattwa Mandal1, Kunal Roy.   

Abstract

Comparative quantitative structure-activity relationship (QSAR) studies have been carried out on tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepine (TIBO) derivatives as reverse transcriptase inhibitors (n=70) using topological, structural, physicochemical, electronic and spatial descriptors. The data set was divided into training and test sets using a cluster-based method. Linear models were developed using multiple regression (with stepwise regression, factor analysis and genetic function approximation (GFA) as variable selection tools) and partial least squares (PLS) and combination of factor analysis and partial least squares (FA-PLS). Genetic function approximation (spline) and artificial neural networks (ANN) were used for the development of non-linear models. Using topological and structural descriptors, the best equation was obtained from GFA (spline) based on internal validation (Q(2)=0.737), but the model with the best external validation characteristics was obtained with FA-PLS (R(pred)(2)=0.707). When structural, physicochemical, electronic and spatial descriptors were used, the best Q(2) (0.740) value was obtained from GFA (spline) whereas PLS provided the best R(pred)(2) (0.784) value. When all descriptors were used in combination, the best R(pred)(2) (0.760) value and the best Q(2) (0.800) value were obtained from ANN and GFA (spline), respectively. The majority of the models satisfied the criteria of external validation recommended by Golbraikh and Tropsha (2002) and the criteria of modified r(2) (r(m)(2)) values of the test set for external validation as suggested by Roy and Roy (2008). In order to further validate selected models, an external set of 10 TIBO derivatives, which fall within the applicability domain of the models and are not shared with the compounds of the present data set, was taken from a different source, and reverse transcriptase inhibitory activity of these compounds was predicted. Acceptable values of squared correlation coefficients between the observed and predicted values of the external set compounds were obtained from the selected models suggesting true predictive potential of the models.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18760864     DOI: 10.1016/j.ejmech.2008.07.020

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

Review 1.  Current mathematical methods used in QSAR/QSPR studies.

Authors:  Peixun Liu; Wei Long
Journal:  Int J Mol Sci       Date:  2009-04-29       Impact factor: 6.208

2.  Prediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression method.

Authors:  Hongying Du; Zhide Hu; Andrea Bazzoli; Yang Zhang
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

3.  Introducing catastrophe-QSAR. Application on modeling molecular mechanisms of pyridinone derivative-type HIV non-nucleoside reverse transcriptase inhibitors.

Authors:  Mihai V Putz; Marius Lazea; Ana-Maria Putz; Corina Duda-Seiman
Journal:  Int J Mol Sci       Date:  2011-12-20       Impact factor: 5.923

4.  A Strategy for Quality Control of Menispermum dauricum DC Based on Cytotoxic Activity and HPLC Fingerprint Analysis.

Authors:  L J Liu; J N Liu
Journal:  Indian J Pharm Sci       Date:  2016 Jan-Feb       Impact factor: 0.975

5.  HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors.

Authors:  Abid Qureshi; Akanksha Rajput; Gazaldeep Kaur; Manoj Kumar
Journal:  J Cheminform       Date:  2018-03-09       Impact factor: 5.514

6.  Evaluation of the antioxidant properties of curcumin derivatives by genetic function algorithm.

Authors:  Ikechukwu Ogadimma Alisi; Adamu Uzairu; Stephen Eyije Abechi; Sulaiman Ola Idris
Journal:  J Adv Res       Date:  2018-03-28       Impact factor: 10.479

7.  In Silico SAR Studies of HIV-1 Inhibitors.

Authors:  Ismail Hdoufane; Imane Bjij; Mahmoud Soliman; Alia Tadjer; Didier Villemin; Jane Bogdanov; Driss Cherqaoui
Journal:  Pharmaceuticals (Basel)       Date:  2018-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.